Prepared Statement of the Federal Trade Commission on "Antitrust Concerns and the FDA Approval Process,” Before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Judiciary Committee, United States House of Representatives
Date
By
Markus H. Meier, Acting Director, Bureau of Competition
Matter Number
P859900
File
Text of the Commission Testimony
(101.52 KB)